| scholarly article | Q13442814 |
| P2093 | author name string | William M Grady | |
| Victoria Valinluck Lao | |||
| P2860 | cites work | DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 |
| Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene | Q22011158 | ||
| DNA methylation patterns and epigenetic memory | Q22065780 | ||
| MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma | Q24315119 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
| CpG island methylation in colorectal cancer: past, present and future | Q24597977 | ||
| Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts | Q24629646 | ||
| The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers | Q24679642 | ||
| 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). | Q24794741 | ||
| Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents | Q27777800 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| CpG islands in vertebrate genomes | Q27861045 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| The genetics of the p53 pathway, apoptosis and cancer therapy | Q27863460 | ||
| Role of histone H3 lysine 27 methylation in Polycomb-group silencing | Q28131795 | ||
| Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
| The cancer epigenome--components and functional correlates | Q28278109 | ||
| Genetic alterations during colorectal-tumor development | Q28281200 | ||
| CpG islands and the regulation of transcription | Q28315762 | ||
| Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes | Q28508338 | ||
| CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
| Epigenetic activation of tumor suppressor microRNAs in human cancer cells | Q36609070 | ||
| PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. | Q36661711 | ||
| Classification of colorectal cancer based on correlation of clinical, morphological and molecular features | Q36699559 | ||
| Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet | Q36741945 | ||
| Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa | Q36755132 | ||
| Epigenetics and aging: the targets and the marks | Q36845462 | ||
| Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers | Q36851776 | ||
| Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. | Q36922505 | ||
| Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. | Q36988762 | ||
| LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. | Q37070832 | ||
| Epigenetic gene regulation in cancer | Q37087598 | ||
| A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer | Q37090752 | ||
| A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation | Q37122031 | ||
| DNA methylation patterns in lung carcinomas | Q37188534 | ||
| Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. | Q37229718 | ||
| MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. | Q37262433 | ||
| Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup? | Q37353936 | ||
| Serrated polyps and colorectal cancer: new pathway to malignancy | Q37463062 | ||
| DNA methylation markers in colorectal cancer | Q37687919 | ||
| Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening | Q37708994 | ||
| Histone modifications and cancer | Q37797690 | ||
| Cancer statistics, 2006 | Q29615133 | ||
| Epigenetics in cancer | Q29617139 | ||
| DNA methylation landscapes: provocative insights from epigenomics | Q29617144 | ||
| The history of cancer epigenetics | Q29617273 | ||
| The DNA methyltransferases of mammals | Q29617317 | ||
| Hypomethylation distinguishes genes of some human cancers from their normal counterparts | Q29619217 | ||
| Epigenetic stem cell signature in cancer | Q29622897 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms | Q30946240 | ||
| Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia | Q33248743 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability | Q33283510 | ||
| Comparing the DNA hypermethylome with gene mutations in human colorectal cancer | Q33300134 | ||
| Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer | Q33337155 | ||
| DNA methylation and chromatin structure: the puzzling CpG islands | Q33340586 | ||
| Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample | Q33383866 | ||
| DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. | Q33517453 | ||
| Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling | Q33520213 | ||
| Three DNA methylation epigenotypes in human colorectal cancer | Q33520394 | ||
| VEZF1 elements mediate protection from DNA methylation | Q33523011 | ||
| Stool DNA and occult blood testing for screen detection of colorectal neoplasia | Q33594565 | ||
| DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. | Q33634174 | ||
| Sensitive digital quantification of DNA methylation in clinical samples | Q33761814 | ||
| CpG island methylator phenotypes in aging and cancer. | Q33765672 | ||
| Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. | Q33770826 | ||
| Genomic and epigenetic instability in colorectal cancer pathogenesis | Q33836026 | ||
| DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer | Q33837632 | ||
| Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor | Q33867627 | ||
| Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP). | Q33869180 | ||
| LINE-1 hypomethylation during primary colon cancer progression | Q33886421 | ||
| Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. | Q33888431 | ||
| Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer | Q33954716 | ||
| Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin | Q33968610 | ||
| Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. | Q33979536 | ||
| Aging, methylation and cancer | Q34016971 | ||
| Cigarette smoking and colorectal cancer risk by molecularly defined subtypes | Q34042268 | ||
| Aberrant epigenetic landscape in cancer: how cellular identity goes awry | Q34149629 | ||
| Two groups of DNA methylation markers to classify colorectal cancer into three epigenotypes | Q37821085 | ||
| Colorectal cancer epigenetics: complex simplicity | Q37827277 | ||
| CpG methylation inhibits binding of several sequence-specific DNA-binding proteins from pea, wheat, soybean and cauliflower | Q38334537 | ||
| Genome-wide quantitative assessment of variation in DNA methylation patterns | Q39600841 | ||
| Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. | Q39688414 | ||
| Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. | Q39835466 | ||
| DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight | Q39853397 | ||
| Gene body-specific methylation on the active X chromosome | Q40166744 | ||
| GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? | Q40471558 | ||
| Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts | Q40623261 | ||
| P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. | Q40667147 | ||
| The role of DNA mismatch repair in platinum drug resistance | Q41155820 | ||
| Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases | Q43735744 | ||
| Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression | Q43796904 | ||
| Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study | Q44552941 | ||
| Effect of calcium supplementation on the risk of large bowel polyps | Q44938210 | ||
| Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer | Q46578998 | ||
| Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage | Q46846179 | ||
| Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability | Q47704165 | ||
| Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. | Q47783677 | ||
| The American College of Gastroenterology Emily Couric Lecture--the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived? | Q48540832 | ||
| Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. | Q51603737 | ||
| Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. | Q51772302 | ||
| DNA motifs associated with aberrant CpG island methylation. | Q51949819 | ||
| Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. | Q53346861 | ||
| Improved fecal DNA test for colorectal cancer screening. | Q54567825 | ||
| Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. | Q54568648 | ||
| A distinct DNA methylation profile associated with microsatellite and chromosomal stable sporadic colorectal cancers. | Q54599567 | ||
| Suppression of intestinal neoplasia by DNA hypomethylation. | Q54613769 | ||
| Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. | Q54650748 | ||
| Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. | Q54794231 | ||
| Profound Flanking Sequence Preference of Dnmt3a and Dnmt3b Mammalian DNA Methyltransferases Shape the Human Epigenome | Q57267655 | ||
| Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer | Q57591268 | ||
| Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression | Q58613225 | ||
| Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence | Q61709335 | ||
| DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs | Q64128252 | ||
| Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression | Q71593229 | ||
| DNA methylation decreases in aging but not in immortal cells | Q71718599 | ||
| Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing | Q71729092 | ||
| E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas | Q71804951 | ||
| Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon | Q72781919 | ||
| Increased cytosine DNA-methyltransferase activity during colon cancer progression | Q72832112 | ||
| Tandem B1 elements located in a mouse methylation center provide a target for de novo DNA methylation | Q73263458 | ||
| Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2 | Q78532732 | ||
| CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma | Q79988265 | ||
| Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA) | Q80418165 | ||
| Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice | Q81441297 | ||
| Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients | Q81622997 | ||
| Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer | Q36606069 | ||
| A simplified, noninvasive stool DNA test for colorectal cancer detection | Q81900521 | ||
| Molecular Genetics of Colorectal Cancer | Q82521439 | ||
| CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer | Q83365535 | ||
| Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns | Q83684001 | ||
| Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon | Q84520702 | ||
| Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas | Q34170505 | ||
| Role for piRNAs and noncoding RNA in de novo DNA methylation of the imprinted mouse Rasgrf1 locus. | Q34184707 | ||
| Mutation and cancer: a model for Wilms' tumor of the kidney | Q34207334 | ||
| Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer | Q34358286 | ||
| Co-evolution of X-chromosome inactivation and imprinting in mammals | Q34409829 | ||
| Colorectal cancer molecular biology moves into clinical practice | Q34425013 | ||
| MGMT promoter methylation and field defect in sporadic colorectal cancer. | Q34452509 | ||
| Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification | Q34564921 | ||
| Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors | Q34573834 | ||
| Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. | Q34574880 | ||
| Altered methylation patterns in cancer cell genomes: cause or consequence? | Q34710435 | ||
| Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer | Q34748786 | ||
| DNA methylation in cancer: too much, but also too little | Q34770545 | ||
| 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. | Q34777582 | ||
| Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer | Q34876473 | ||
| DNA methylation predicts recurrence from resected stage III proximal colon cancer | Q35051119 | ||
| Cancer epigenetics: linking basic biology to clinical medicine. | Q35348043 | ||
| A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability | Q35594520 | ||
| Genome-scale analysis of aberrant DNA methylation in colorectal cancer | Q35694387 | ||
| CpG island methylation in colorectal adenomas | Q35746792 | ||
| CpG island methylation in aberrant crypt foci of the colorectum | Q35748049 | ||
| CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies | Q35760749 | ||
| CpG methylation as a mechanism for the regulation of E2F activity | Q35776918 | ||
| Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
| CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations | Q35807863 | ||
| CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 | Q35848528 | ||
| Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample | Q35855515 | ||
| The epigenetics of cancer etiology | Q35920461 | ||
| Biochemistry and biology of mammalian DNA methyltransferases | Q35939026 | ||
| Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis | Q36175129 | ||
| Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. | Q36276940 | ||
| Molecular classification and correlates in colorectal cancer | Q36329300 | ||
| Concordant DNA methylation in synchronous colorectal carcinomas. | Q36529752 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 686-700 | |
| P577 | publication date | 2011-10-18 | |
| P1433 | published in | Nature Reviews Gastroenterology & Hepatology | Q2108255 |
| P1476 | title | Epigenetics and colorectal cancer | |
| P478 | volume | 8 |
| Q61817187 | -6 Linoleic Acid Induces Epigenetics Alterations Associated with Colonic Inflammation and Cancer |
| Q52568288 | A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. |
| Q49328268 | A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining |
| Q41956283 | A panel of genes methylated with high frequency in colorectal cancer |
| Q40512450 | A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets |
| Q36974863 | A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification |
| Q50453970 | A supercharged fluorescent protein as a versatile probe for homogeneous DNA detection and methylation analysis. |
| Q36502335 | A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors |
| Q49668158 | Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? |
| Q40121556 | Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer |
| Q36962957 | Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC. |
| Q49360423 | Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial. |
| Q35750355 | Aberrant methylation patterns in cancer: a clinical view |
| Q37706504 | Aberrant methylation patterns in colorectal cancer: a meta-analysis |
| Q35102447 | Aberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis |
| Q37578731 | Accumulation of aberrant DNA methylation during colorectal cancer development |
| Q93226610 | Altered ARID1A expression in colorectal cancer |
| Q91617739 | An evaluation of supervised methods for identifying differentially methylated regions in Illumina methylation arrays |
| Q33732199 | Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review |
| Q97525750 | Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance |
| Q38813562 | Antitumor Activity of Total Flavonoids from Daphne genkwa in Colorectal Cancer |
| Q26738304 | Apoptotic pathways as a therapeutic target for colorectal cancer treatment |
| Q40975165 | Application of artificial neural networks to link genetic and environmental factors to DNA methylation in colorectal cancer. |
| Q38036541 | Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms |
| Q37094281 | Aspirin use and risk of colorectal cancer according to BRAF mutation status |
| Q37230808 | Association between circulating concentrations of 25(OH)D and colorectal adenoma: a pooled analysis |
| Q35098078 | Association between six genetic polymorphisms and colorectal cancer: a meta-analysis |
| Q42172731 | Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population. |
| Q34991195 | Associations between S-adenosylmethionine, S-adenosylhomocysteine, and colorectal adenoma risk are modified by sex. |
| Q98157804 | Associations between nutritional factors and KRAS mutations in colorectal cancer: a systematic review |
| Q41914792 | Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. |
| Q49771879 | BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer. |
| Q37516120 | Black raspberries protectively regulate methylation of Wnt pathway genes in precancerous colon tissue |
| Q26773761 | Breast cancer intrinsic subtype classification, clinical use and future trends |
| Q36515055 | CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer |
| Q36067682 | CD80 down-regulation is associated to aberrant DNA methylation in non-inflammatory colon carcinogenesis |
| Q51323679 | Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? |
| Q42559167 | Can we change the past for colorectal cancer patients and how do we move forward? |
| Q35034857 | Cancer-predicting gene expression changes in colonic mucosa of Western diet fed Mlh1+/- mice |
| Q39258008 | Case-control study of candidate gene methylation and adenomatous polyp formation |
| Q58693501 | Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women |
| Q58714578 | Chromatin de-condensation by switching substrate elasticity |
| Q38949945 | Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines |
| Q92469456 | Circulating epigenetic biomarkers for detection of recurrent colorectal cancer |
| Q27027560 | Clinical advances in molecular biomarkers for cancer diagnosis and therapy |
| Q38380481 | Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples. |
| Q36095281 | Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma |
| Q28647615 | Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach |
| Q30238915 | Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer |
| Q89218269 | Colorectal cancer |
| Q36849645 | Colorectal cancer carcinogenesis: a review of mechanisms |
| Q35935945 | Colorectal cancer: a tale of two sides or a continuum? |
| Q46112381 | Colorectal cancer: epigenetic alterations and their clinical implications. |
| Q35152312 | Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas |
| Q36195885 | Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle |
| Q36563162 | Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma |
| Q34550961 | Comparison study of MS-HRM and pyrosequencing techniques for quantification of APC and CDKN2A gene methylation |
| Q38365443 | Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic. |
| Q36487348 | Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers |
| Q35643491 | Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis. |
| Q36183202 | Correlation of NGX6 expression with clinicopathologic features and prognosis in colon cancer |
| Q37702124 | Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway |
| Q35915669 | Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1 |
| Q36601457 | DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer |
| Q36301656 | DNA Methylation Dynamics During Differentiation, Proliferation, and Tumorigenesis in the Intestinal Tract |
| Q38314840 | DNA Methylation and Colorectal Cancer |
| Q35878544 | DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas |
| Q34603514 | DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. |
| Q56890318 | DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer |
| Q64947267 | DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression. |
| Q35224793 | DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study |
| Q39377846 | DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review |
| Q52652017 | DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. |
| Q27324785 | DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer |
| Q89717427 | DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E Mutation |
| Q48146931 | DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. |
| Q40627933 | Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis |
| Q61197458 | Detection and differential diagnosis of colon cancer by a cumulative analysis of promoter methylation |
| Q42267500 | Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method. |
| Q33661249 | Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer |
| Q57177421 | Diagnostic Value of Methylated for Colorectal Cancer Detection |
| Q38610743 | Diagnostic and prognostic epigenetic biomarkers in cancer |
| Q28239338 | Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer |
| Q36775698 | Differential DNA methylation patterns of homeobox genes in proximal and distal colon epithelial cells. |
| Q54232902 | Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. |
| Q27011884 | Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology |
| Q37624345 | Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer |
| Q89735561 | Downregulation of the Helicase Lymphoid-Specific (HELLS) Gene Impairs Cell Proliferation and Induces Cell Cycle Arrest in Colorectal Cancer Cells |
| Q37061363 | Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers |
| Q92533188 | Effects of obesity and weight loss on mitochondrial structure and function and implications for colorectal cancer risk |
| Q28087759 | Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer |
| Q28816966 | Endoplasmic reticulum stress and IRE-1 signaling cause apoptosis in colon cancer cells in response to andrographolide treatment |
| Q37402226 | Environmental epigenetics: from novelty to scientific discipline |
| Q33661094 | Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention |
| Q34487177 | Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers |
| Q38671092 | Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer |
| Q92479179 | Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies |
| Q38018997 | Epigenetic biomarkers in colorectal cancer diagnostics |
| Q48246494 | Epigenetic inactivation of RUNX3 in colorectal cancer |
| Q36616423 | Epigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibility |
| Q36286662 | Epigenetic mechanisms in commonly occurring cancers. |
| Q37587537 | Epigenetic research in cancer epidemiology: trends, opportunities, and challenges |
| Q33597607 | Epigenetic silencing of protocadherin 10 in colorectal cancer |
| Q37385238 | Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. |
| Q36907727 | Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior |
| Q37061792 | Epigenetics and colorectal cancer pathogenesis |
| Q38195260 | Epigenetics and oncology |
| Q28071714 | Epigenetics in diagnosis of colorectal cancer |
| Q24598045 | Epigenetics of colorectal cancer |
| Q92407472 | Epigenetics of colorectal cancer: biomarker and therapeutic potential |
| Q41050138 | Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers |
| Q38901400 | Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance |
| Q26852716 | Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression |
| Q61454440 | Evaluation of Novel 3-Hydroxyflavone Analogues as HDAC Inhibitors against Colorectal Cancer |
| Q91618178 | Evaluation of colorectal cancer subtypes and cell lines using deep learning |
| Q37162458 | Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis |
| Q35042626 | Exome Sequencing of Normal and Isogenic Transformed Human Colonic Epithelial Cells (HCECs) Reveals Novel Genes Potentially Involved in the Early Stages of Colorectal Tumorigenesis |
| Q96155614 | Exploration of Potential Roles of m6A Regulators in Colorectal Cancer Prognosis |
| Q35650849 | Expression and new exon mutations of the human Beta defensins and their association on colon cancer development |
| Q38826119 | Expression of FOXP1 and Colorectal Cancer Prognosis |
| Q38205339 | Familial colorectal cancer type X: genetic profiles and phenotypic features. |
| Q27852581 | Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer |
| Q34416852 | Field cancerization in the colon: a role for aberrant DNA methylation? |
| Q34347646 | From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer |
| Q50026061 | Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer |
| Q51571013 | G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway. |
| Q55443533 | Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations. |
| Q34000439 | Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism |
| Q33598237 | Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer |
| Q57283817 | Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice |
| Q37578728 | Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer |
| Q38676702 | Genetic and epigenetic markers in colorectal cancer screening: recent advances |
| Q42290036 | Genetic and epigenetic profiling of a solitary Peutz-Jeghers colon polyp. |
| Q53242589 | Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. |
| Q64119959 | Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer |
| Q34749665 | HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure |
| Q47927828 | Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis |
| Q58791615 | Homeobox oncogene activation by pan-cancer DNA hypermethylation |
| Q26992045 | How many molecular subtypes? Implications of the unique tumor principle in personalized medicine |
| Q94544685 | Hydroxypropyl-β-Cyclodextrin Complexes of Styryllactones Enhance the Anti-Tumor Effect in SW1116 Cell Line |
| Q41028438 | Hypermethylation of ITGA4, TFPI2 and VIMENTIN promoters is increased in inflamed colon tissue: putative risk markers for colitis-associated cancer |
| Q55263360 | Hypermethylation of protocadherin γ subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer. |
| Q36121608 | Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis. |
| Q37637537 | Identification of Predictive DNA Methylation Biomarkers for Chemotherapy Response in Colorectal Cancer |
| Q30956148 | Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data |
| Q37582033 | Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer |
| Q36572153 | Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients |
| Q64958443 | Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival. |
| Q92246769 | Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3 |
| Q91779976 | Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. 'cannabinoid exposure and altered DNA methylation in rat and human sperm' epigenetics 2018; 13: 1208-1221 |
| Q89599803 | Improving prediction performance of colon cancer prognosis based on the integration of clinical and multi-omics data |
| Q34662592 | Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis |
| Q33597778 | Integrating genetic and genomic information into effective cancer care in diverse populations |
| Q36463854 | Integration of molecular pathology, epidemiology and social science for global precision medicine |
| Q50043586 | Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine |
| Q90640128 | Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer |
| Q64110806 | JAM3 functions as a novel tumor suppressor and is inactivated by DNA methylation in colorectal cancer |
| Q52597337 | KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells. |
| Q35227430 | KeyPathwayMiner 4.0: condition-specific pathway analysis by combining multiple omics studies and networks with Cytoscape. |
| Q34661887 | Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population |
| Q99708802 | Landscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis |
| Q38194035 | Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application |
| Q36194410 | Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors. |
| Q37376407 | MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect |
| Q64955692 | Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. |
| Q36323781 | Methylation diet and methyl group genetics in risk for adenomatous polyp occurrence |
| Q40522662 | MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition. |
| Q99239609 | MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer |
| Q37075412 | Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication |
| Q34485631 | Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage. |
| Q39308037 | Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates |
| Q27002450 | Molecular biomarkers for the detection of metastatic colorectal cancer cells |
| Q27010063 | Molecular markers for colorectal cancer screening |
| Q24289344 | Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease |
| Q64101405 | Mucinous colorectal adenocarcinoma: clinical pathology and treatment options |
| Q37148924 | Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in oligodendroglial tumors. |
| Q98159009 | Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening |
| Q39306327 | New insights into the earliest stages of colorectal tumorigenesis |
| Q36059870 | No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. |
| Q36238964 | Novel derivative of aminobenzenesulfonamide (3c) induces apoptosis in colorectal cancer cells through ROS generation and inhibits cell migration |
| Q38114502 | Novel drug discovery opportunities for colorectal cancer |
| Q36610385 | Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa |
| Q95725436 | O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer |
| Q37074078 | Obesity promotes PhIP-induced small intestinal carcinogenesis in hCYP1A-db/db mice: involvement of mutations and DNA hypermethylation of Apc. |
| Q34296789 | Ogino et Al. Respond to "the 21st century epidemiologist". |
| Q61632631 | Overcoming Drug Resistance in Colorectal Cancer by MicroRNAs |
| Q33767601 | PCDH18 is frequently inactivated by promoter methylation in colorectal cancer |
| Q36546764 | PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms |
| Q36926941 | Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer |
| Q92482187 | Polyunsaturated fatty acids and DNA methylation in colorectal cancer |
| Q91529267 | Positive expression of basic transcription factor 3 predicts poor survival of colorectal cancer patients: possible mechanisms involved |
| Q91756140 | Potential proapoptotic phytochemical agents for the treatment and prevention of colorectal cancer |
| Q37360360 | Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. |
| Q35729861 | Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803 |
| Q34475686 | Proceedings of the second international molecular pathological epidemiology (MPE) meeting |
| Q90319523 | Prognostic and Predictive Epigenetic Biomarkers in Oncology |
| Q36220792 | Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer |
| Q38321611 | Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review |
| Q34016833 | Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions |
| Q37000981 | Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis |
| Q35138892 | Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer |
| Q56519160 | Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies |
| Q34762217 | Promoter methylation of tumor suppressor genes in pre-neoplastic lesions; potential marker of disease recurrence. |
| Q36535688 | Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level |
| Q89591419 | Protein Kinase A Inhibitor H89 Attenuates Experimental Proliferative Vitreoretinopathy |
| Q38194582 | Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers |
| Q40413351 | Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patients. |
| Q38687680 | RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis |
| Q92053513 | Role of DNA Methylation in the Development and Differentiation of Intestinal Epithelial Cells and Smooth Muscle Cells |
| Q64974753 | Role of epigenetics in transformation of inflammation into colorectal cancer. |
| Q42353627 | Role of tissue microenvironment resident adipocytes in colon cancer |
| Q35040035 | S100P, a calcium-binding protein, is preferentially associated with the growth of polypoid tumors in colorectal cancer |
| Q34458644 | SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features |
| Q26751035 | Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy |
| Q47797356 | Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma |
| Q92654720 | Silencing of synaptotagmin 13 inhibits tumor growth through suppressing proliferation and promoting apoptosis of colorectal cancer cells |
| Q37603495 | Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer |
| Q64108499 | Small non-coding RNA and colorectal cancer |
| Q99241205 | Stabilization of oncogenic transcripts by the IGF2BP3/ELAVL1 complex promotes tumorigenicity in colorectal cancer |
| Q38954637 | Study of apoptosis-related interactions in colorectal cancer |
| Q92255186 | Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment |
| Q92738272 | TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process |
| Q39471157 | Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus |
| Q27027266 | Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilus |
| Q28247866 | The BRAF oncoprotein functions through the transcriptional repressor MAFG to mediate the CpG Island Methylator phenotype |
| Q33596629 | The CpG island methylator phenotype (CIMP) in colorectal cancer |
| Q38870781 | The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma. |
| Q39456907 | The Immune Biology of Microsatellite-Unstable Cancer |
| Q26745580 | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment |
| Q36261529 | The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis |
| Q91678604 | The activating transcription factor 2: an influencer of cancer progression |
| Q37699177 | The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. |
| Q38210477 | The effect of diet on the intestinal epigenome |
| Q58636039 | The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis |
| Q90341405 | The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis |
| Q37644797 | The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent |
| Q34139192 | The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner |
| Q55233897 | The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy. |
| Q53326236 | The potential role of the NEK6, AURKA, AURKB, and PAK1 genes in adenomatous colorectal polyps and colorectal adenocarcinoma. |
| Q36476282 | The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation |
| Q50333457 | The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer |
| Q48266694 | The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer |
| Q38770200 | The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth |
| Q38215665 | The role of epigenetics in colorectal cancer |
| Q91689817 | Toll-like receptor 6 expression, sequence variants, and their association with colorectal cancer risk |
| Q49963185 | Transcriptome and DNA Methylome Analysis in a Mouse Model of Diet-Induced Obesity Predicts Increased Risk of Colorectal Cancer. |
| Q64965261 | Transcutaneous Vagus Nerve Stimulation Regulates the Cholinergic Anti-inflammatory Pathway to Counteract 1, 2-Dimethylhydrazine Induced Colon Carcinogenesis in Albino wistar Rats. |
| Q50642659 | Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity. |
| Q37631429 | Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer. |
| Q34169734 | Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis |
| Q39194701 | Tumor suppressor genes in familial adenomatous polyposis |
| Q28069898 | Tumour biomarkers: homeostasis as a novel prognostic indicator |
| Q37708920 | Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis. |
| Q54979868 | Update on Sporadic Colorectal Cancer Genetics. |
| Q33859385 | Validation of methylation biomarkers that distinguish normal colon mucosa of cancer patients from normal colon mucosa of patients without cancer |
| Q58697697 | Vitamin C promotes decitabine or azacytidine induced DNA hydroxymethylation and subsequent reactivation of the epigenetically silenced tumour suppressor in colon cancer cells |
| Q26766256 | Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence |
| Q41111994 | WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy |
| Q37651410 | Zebrafish Discoveries in Cancer Epigenetics. |
Search more.